Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose

Hiroshi Bando^1,2,3*, Hiroko Ogawa³, Shinji Nagahiro³, Miwako Nakanishi³, Osami Watanabe^3
1Medical Research/Tokushima University, Tokushima, Japan
²Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan
³Yoshinogawa Hospital, Tokushima, Japan

Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ^{ORCID iD}
Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan.
Received date: 16 April 2021; Accepted date: 30 April 2021; Published date: 08 June 2021

Citation: Bando H, Ogawa H, Nagahiro S, Nakanishi M, Watanabe O. Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose. Diab Res Open Access. 2021 Jun 08;3(2):23-29.

Copyright © 2021 Bando H, Ogawa H, Nagahiro S, Nakanishi M, Watanabe O. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Xultophy, Insulin Degludec and Liraglutide, Humalog Mix 25, Type 2 Diabetes Mellitus, Bio-Psycho-Social

Abbreviations: IDeg/Lira: Insulin Degludec and Liraglutide; T2DM; Type 2 Diabetes Mellitus; LCD: Low Carbohydrate Diet; CR: Calorie Restriction

Abstract

The patient was a 74-year-old female with type 2 diabetes mellitus (T2DM) treated on Humalog mix 25 twice a day. As social history, she has worked long years for growing and harvesting lotus roots. It gives physically heavy loading, which brings unstable glycemic daily control. She had to titrate minute regulation every time. For stable glucose variability, the treatment was changed to Xultophy, which is a specific combined agent of Insulin Degludec and Liraglutide (IDeg/Lira) once a day. Then, detailed glucose monitoring showed a better daily profile of blood glucose, irrespective of heavy or light work. It showed the bio-psycho-social benefit of Xultophy.